BioCentury | Apr 18, 2011
Company News

Compass, PanGen Biotech Inc. deal

Compass (formerly Cyplasin Biomedical Ltd.) and PanGen signed a memorandum of understanding under which PanGen will produce active pharmaceutical ingredients (APIs) which will be used by Compass to produce biosimilars. Compass will have rights to...
BioCentury | Feb 3, 2003
Company News

NaPro, Pangene deal

...NPRO purchased the genomics business of Pangene, which includes instruments, software and IP relating to Pangene's...
...be relocated to NPRO's genomics facility in Newark, Del. NaPro BioTherapeutics Inc. (NPRO), Boulder, Colo. Pangene Corp....
BioCentury | Jan 27, 2003
Company News

NaPro acquires Pangene's genomics business

...the genomics business of Pangene (Fremont, Calif.), which includes instruments, software and IP relating to Pangene's...
...functional genomics business. The assets will be relocated to NPRO's genomics facility in Newark, Delaware. Pangene...
BioCentury | Oct 1, 2001
Company News

Pangene other research news

...to develop inhibitors of DNA repair enzymes including DSBR and BER to treat breast cancer. Pangene...
...to radiation therapy and DNA damaging chemotherapy. The value of the grant was not disclosed. Pangene Corp....
BioCentury | May 29, 2001
Company News

Pangene sales and marketing update

...web portal through which customers may access its gene cloning and drug development platform technologies. Pangene Corp....
BioCentury | Nov 13, 2000
Finance

Schroder's plans for IBT

...to work. It has put a bit less than $10 million into recent investments in Pangene...
BioCentury | Sep 18, 2000
Company News

Akkadix, Pangene deal

...Akkadix received an exclusive license to Pangene's enhanced Homologous Recombination (eHR) technology for DNA modification and...
...modification and rearrangement in plant science applications, and received a non-exclusive license for DNA cloning. Pangene...
...to licensed technologies. Pangene is a shareholder in Akkadix. Akkadix Corp. , La Jolla, Calif. Pangene Corp....
BioCentury | Sep 14, 2000
Company News

Akkadix licensing deal with Pangene

...Akkadix (La Jolla, Calif.) received an exclusive license to Pangene's enhanced Homologous Recombination (eHR) platform for...
...plant science applications. Akkadix also received a non-exclusive license to the technology for DNA cloning. Pangene...
Items per page:
1 - 8 of 8
BioCentury | Apr 18, 2011
Company News

Compass, PanGen Biotech Inc. deal

Compass (formerly Cyplasin Biomedical Ltd.) and PanGen signed a memorandum of understanding under which PanGen will produce active pharmaceutical ingredients (APIs) which will be used by Compass to produce biosimilars. Compass will have rights to...
BioCentury | Feb 3, 2003
Company News

NaPro, Pangene deal

...NPRO purchased the genomics business of Pangene, which includes instruments, software and IP relating to Pangene's...
...be relocated to NPRO's genomics facility in Newark, Del. NaPro BioTherapeutics Inc. (NPRO), Boulder, Colo. Pangene Corp....
BioCentury | Jan 27, 2003
Company News

NaPro acquires Pangene's genomics business

...the genomics business of Pangene (Fremont, Calif.), which includes instruments, software and IP relating to Pangene's...
...functional genomics business. The assets will be relocated to NPRO's genomics facility in Newark, Delaware. Pangene...
BioCentury | Oct 1, 2001
Company News

Pangene other research news

...to develop inhibitors of DNA repair enzymes including DSBR and BER to treat breast cancer. Pangene...
...to radiation therapy and DNA damaging chemotherapy. The value of the grant was not disclosed. Pangene Corp....
BioCentury | May 29, 2001
Company News

Pangene sales and marketing update

...web portal through which customers may access its gene cloning and drug development platform technologies. Pangene Corp....
BioCentury | Nov 13, 2000
Finance

Schroder's plans for IBT

...to work. It has put a bit less than $10 million into recent investments in Pangene...
BioCentury | Sep 18, 2000
Company News

Akkadix, Pangene deal

...Akkadix received an exclusive license to Pangene's enhanced Homologous Recombination (eHR) technology for DNA modification and...
...modification and rearrangement in plant science applications, and received a non-exclusive license for DNA cloning. Pangene...
...to licensed technologies. Pangene is a shareholder in Akkadix. Akkadix Corp. , La Jolla, Calif. Pangene Corp....
BioCentury | Sep 14, 2000
Company News

Akkadix licensing deal with Pangene

...Akkadix (La Jolla, Calif.) received an exclusive license to Pangene's enhanced Homologous Recombination (eHR) platform for...
...plant science applications. Akkadix also received a non-exclusive license to the technology for DNA cloning. Pangene...
Items per page:
1 - 8 of 8